| Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas NV Adsay, K Merati, O Basturk, C Iacobuzio-Donahue, E Levi, JD Cheng, ... The American journal of surgical pathology 28 (7), 839-848, 2004 | 513 | 2004 |
| Curcumin synergizes with resveratrol to inhibit colon cancer APN Majumdar, S Banerjee, J Nautiyal, BB Patel, V Patel, J Du, Y Yu, ... Nutrition and cancer 61 (4), 544-553, 2009 | 244 | 2009 |
| T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases O Dereure, E Levi, ME Kadin Archives of dermatology 136 (12), 1483-1486, 2000 | 184 | 2000 |
| Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF S Roy, E Levi, APN Majumdar, FH Sarkar Journal of hematology & oncology 5, 1-6, 2012 | 177 | 2012 |
| A deletion in the gene for transforming growth factor β type I receptor abolishes growth regulation by transforming growth factor β in a cutaneous T-cell lymphoma WP Schiemann, WM Pfeifer, E Levi, ME Kadin, HF Lodish Blood, The Journal of the American Society of Hematology 94 (8), 2854-2861, 1999 | 174 | 1999 |
| Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies SA Sakowski, TJ Geddes, DM Thomas, E Levi, JS Hatfield, DM Kuhn Brain research 1085 (1), 11-18, 2006 | 170 | 2006 |
| miR-21 and miR-145 cooperation in regulation of colon cancer stem cells Y Yu, P Nangia-Makker, L Farhana, S G. Rajendra, E Levi, ... Molecular cancer 14, 1-11, 2015 | 166 | 2015 |
| MUC1 and MUC2 in pancreatic neoplasia E Levi, DS Klimstra, NV Adsay, A Andea, O Basturk Journal of clinical pathology 57 (5), 456-462, 2004 | 153 | 2004 |
| Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial R Jaszewski, S Misra, M Tobi, N Ullah, JA Naumoff, O Kucuk, E Levi, ... World journal of gastroenterology 14 (28), 4492, 2008 | 149 | 2008 |
| Metformin: a potential therapeutic agent for recurrent colon cancer P Nangia-Makker, Y Yu, A Vasudevan, L Farhana, SG Rajendra, E Levi, ... PloS one 9 (1), e84369, 2014 | 141 | 2014 |
| Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin O Dereure, E Levi, ME Kadin, EC Vonderheid Journal of investigative dermatology 118 (6), 949-956, 2002 | 125 | 2002 |
| A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma NV Adsay, O Basturk, M Bonnett, N Kilinc, AA Andea, J Feng, M Che, ... The American journal of surgical pathology 29 (6), 724-733, 2005 | 114 | 2005 |
| Cell cycle-and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor AK Rishi, L Zhang, Y Yu, Y Jiang, J Nautiyal, A Wali, JA Fontana, E Levi, ... Journal of Biological Chemistry 281 (19), 13188-13198, 2006 | 88 | 2006 |
| Mechanisms of curcumin-and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells S Reddy, AK Rishi, H Xu, E Levi, FH Sarkar, APN Majumdar Nutrition and cancer 55 (2), 185-194, 2006 | 82 | 2006 |
| Fascin expression in CD30‐positive cutaneous lymphoproliferative disorders W Kempf, E Levi, J Kamarashev, H Kutzner, W Pfeifer, ... Journal of cutaneous pathology 29 (5), 295-300, 2002 | 77 | 2002 |
| Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer BB Patel, Y Yu, J Du, E Levi, PA Phillip, APN Majumdar Biochemical and biophysical research communications 378 (3), 344-347, 2009 | 69 | 2009 |
| Transactivator of transcription–tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo L Zhang, E Levi, P Majumder, Y Yu, A Aboukameel, J Du, H Xu, ... Molecular cancer therapeutics 6 (5), 1661-1672, 2007 | 67 | 2007 |
| A murine xenograft model for human CD30+ anaplastic large cell lymphoma: successful growth inhibition with an anti-CD30 antibody (HeFi-1) W Pfeifer, E Levi, T Petrogiannis-Haliotis, L Lehmann, Z Wang, ME Kadin The American journal of pathology 155 (4), 1353-1359, 1999 | 62 | 1999 |
| Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer A Vasudevan, Y Yu, S Banerjee, J Woods, L Farhana, SG Rajendra, ... Cancer Prevention Research 7 (11), 1138-1148, 2014 | 55 | 2014 |
| Hematological and hemorheological effects of air pollution OK Baskurt, E Levi, S Caglayan, N Dikmenoglu, MN Kutman Archives of Environmental Health: An International Journal 45 (4), 224-228, 1990 | 55 | 1990 |
